Request a Sample Report on Cytomegalovirus Infection Market Size
Featured Treatments:
mRNA-1647 (ModernaTX, Inc.)
Letermovir 480 MG [Prevymis] (Merck Sharp & Dohme LLC)
Pentamer(low)/gB(low)/adjuvant vaccine (GlaxoSmithKline)
Posoleucel (ALVR105) (AlloVir)
Latest clinical trial results:
February 2025: Takeda Pharmaceutical announces results of a safety and efficacy evaluation study of Maribavir in hematopoietic stem cell transplant (HSCT) patients .
December 2024: ModernaTX, Inc. announces results from a Phase 3 trial of its mRNA-1647 vaccine in healthy 16-40 year olds .
June 2024: SymBio Pharmaceuticals announces results from a Phase IIa trial of Brincidofovir in patients with CMV and adenovirus infections .
February 2024: A study from Weill Cornell Medicine suggests that an mRNA vaccine (phase 3 trial) significantly improves the immune response against CMV infection .
Find out which treatments are expected to capture the Cytomegalovirus Infection market share @Cytomegalovirus Infection Treatment Market Report
CMV (cytomegalovirus) is classified as herpesvirus type 5 and can range from asymptomatic to fever and fatigue, and can also have serious effects on the eyes, brain, and internal organs . Although it is unlikely to develop in healthy individuals , it can cause serious complications in immunosuppressed patients .
It is estimated that 60-90% of adults have been infected with CMV, which remains latent after infection and can reactivate when the immune system is weakened .
Request a Sample Report @Cytomegalovirus Infection Market Size
Research period: 2020-2034
Target Markets: 7MM (US, EU4, UK, Japan)
Major companies: ModernaTX, Inc., Merck Sharp & Dohme LLC, GlaxoSmithKline, AlloVir, etc.
Main treatments: mRNA-1647, Letermovir 480 MG [Prevymis], Pentamer (low)/gB(low)/adjuvant vaccine, Posoleucel (ALVR105), etc.
Market analysis: evaluation of existing and new treatments, SWOT analysis, market entry strategies
Find out which treatments will capture Cytomegalovirus Infection market share @Cytomegalovirus Infection Treatment Market Report
Contact Information:
Himanshu
humason@delveinsight.com
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading business consultancy and market research firm focused on life sciences, supporting pharmaceutical companies by providing comprehensive end-to-end solutions to improve their business performance.